Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 91 articles:
HTML format



Single Articles


    November 2021
  1. IMAI N, Yokoyama S, Yamamoto K, Ito T, et al
    Safety and Efficacy of Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Hepatocellular Carcinoma: First Clinical Outcomes.
    Anticancer Res. 2021;41:5817-5820.
    PubMed     Abstract available


  2. OMIYA S, Komatsu S, Kido M, Kuramitsu K, et al
    Impact of Sarcopenia as a Prognostic Factor on Reductive Hepatectomy for Advanced Hepatocellular Carcinoma.
    Anticancer Res. 2021;41:5775-5783.
    PubMed     Abstract available


  3. ADACHI Y, Yamamura K, Yumoto S, Higashi T, et al
    Far-advanced Colorectal Liver Metastases Successfully Managed With Modified ALPPS and Radiofrequency Ablation in Combination With Chemotherapy.
    Anticancer Res. 2021;41:5855-5861.
    PubMed     Abstract available


  4. FURUKAWA K, Onda S, Taniai T, Hamura R, et al
    Risk Factors and Overcoming Strategies of Surgical Site Infection After Hepatectomy for Colorectal Liver Metastases.
    Anticancer Res. 2021;41:5651-5656.
    PubMed     Abstract available


  5. MASATSUNE S, Kimura K, Kashiwagi S, En W, et al
    Impact of Intraoperative Blood Loss and Blood Transfusion on the Prognosis of Colorectal Liver Metastasis Following Curative Resection.
    Anticancer Res. 2021;41:5617-5623.
    PubMed     Abstract available


  6. TAGO T, Katsumata K, Udou R, Kasahara K, et al
    Significance of Radiofrequency Ablation for Unresectable Colorectal Cancer With Liver Metastases.
    Anticancer Res. 2021;41:5539-5547.
    PubMed     Abstract available


  7. TSOCHANTARIDIS I, Voulgaridou GP, Giatromanolaki A, Koukourakis MI, et al
    Profiling of Aldehyde Dehydrogenase Isoforms in In Vitro Formed Tumorspheres.
    Anticancer Res. 2021;41:5481-5488.
    PubMed     Abstract available


    October 2021
  8. ODA E, Yamamura K, Hara Y, Matsumura K, et al
    Intrahepatic Cholangiocarcinoma Coexisting With Multiple Bile Duct Adenoma Treated as Liver Metastasis from a Pancreatic Neuroendocrine Tumor.
    Anticancer Res. 2021;41:5249-5254.
    PubMed     Abstract available


  9. KIM M, Kim HC, Chung JW
    Chemoembolization for Hepatocellular Carcinoma in Patients With Inferior Vena Caval/Right Atrial Tumor Thrombi Without Hepatic Vein Invasion.
    Anticancer Res. 2021;41:5241-5247.
    PubMed     Abstract available


  10. MOON H, Park H, Ro SW
    c-Myc-driven Hepatocarcinogenesis.
    Anticancer Res. 2021;41:4937-4946.
    PubMed     Abstract available


    September 2021
  11. KOMATSU S, Yano Y, Kido M, Kuramitsu K, et al
    Lenvatinib Rechallenge After Ramucirumab Treatment Failure for Hepatocellular Carcinoma.
    Anticancer Res. 2021;41:4555-4562.
    PubMed     Abstract available


  12. OKAMOTO H, Shiba S, Iino H, Sudoh M, et al
    Tumor Vascular Microenvironment of Colorectal Hepatic Metastasis and Chemotherapy Response.
    Anticancer Res. 2021;41:4505-4513.
    PubMed     Abstract available


  13. TSUNEMATSU M, Onda S, Yanagaki M, Okui N, et al
    How to Perform Curative Laparoscopic Hepatectomy for Intraoperatively Unidentified Hepatocellular Carcinoma.
    Anticancer Res. 2021;41:4411-4416.
    PubMed     Abstract available


  14. TOKUDA K, Morine Y, Miyazaki K, Yamada S, et al
    Frailty Can Predict Prognosis After Hepatectomy in Patients With Colorectal Liver Metastasis.
    Anticancer Res. 2021;41:4637-4644.
    PubMed     Abstract available


    August 2021
  15. YAMANAKA M, Hayashi M, Yamada S, Sonohara F, et al
    A Possible Definition of Oligometastasis in Pancreatic Cancer and Associated Survival Outcomes.
    Anticancer Res. 2021;41:3933-3940.
    PubMed     Abstract available


  16. OURA K, Aoki T, Tashiro Y, Matsuda K, et al
    Indocyanine Green Fluorescence Image-guided Laparoscopic Hepatectomy Enabled Resection of a Tumor Invisible With Ultrasonography.
    Anticancer Res. 2021;41:3867-3869.
    PubMed     Abstract available


    July 2021
  17. KUBO H, Ikoma H, Yamamoto Y, Morimura R, et al
    Therapeutic Strategy of Colorectal Liver Metastasis Using Modified-JHBPS Nomogram.
    Anticancer Res. 2021;41:3657-3665.
    PubMed     Abstract available


  18. VIEIRA JF, Peixoto AP, Murta EFC, Michelin MA, et al
    Prophylactic Dendritic Cell Vaccination in Experimental Breast Cancer Controls Immunity and Hepatic Metastases.
    Anticancer Res. 2021;41:3419-3427.
    PubMed     Abstract available


    June 2021
  19. AU KY, Chan KK, Lo RC
    A Clinicopathological Study of Young-onset Hepatocellular Carcinoma.
    Anticancer Res. 2021;41:2933-2944.
    PubMed     Abstract available


    May 2021
  20. YAMAMURA K, Beppu T, Oda E, Sato N, et al
    Hepatic Inflammatory Pseudotumor Mimicking Malignant Tumor With Rare Onset of Intra-abdominal Hemorrhage.
    Anticancer Res. 2021;41:2727-2732.
    PubMed     Abstract available


  21. KIM HC, Choi JW, Lee M, Kim YJ, et al
    Yttrium-90 Radioembolization for Hepatocellular Carcinoma: Virtual Tumor Absorbed Dose as a Predictor of Complete Response.
    Anticancer Res. 2021;41:2625-2635.
    PubMed     Abstract available


  22. YAMAMOTO T, Imai N, Yamamoto K, Ito T, et al
    Tolerability of Molecular-targeted Agents for Hepatocellular Carcinoma Treatment in Haemophiliacs.
    Anticancer Res. 2021;41:2569-2573.
    PubMed     Abstract available


  23. ISHIGAMI I, Shuwari N, Kaminade T, Mizuguchi H, et al
    A TGFbeta Signaling Inhibitor, SB431542, Inhibits Reovirus-mediated Lysis of Human Hepatocellular Carcinoma Cells in a TGFbeta-independent Manner.
    Anticancer Res. 2021;41:2431-2440.
    PubMed     Abstract available


  24. SHIBUTANI M, Kimura K, Kashiwagi S, Wang EN, et al
    Elevated Postoperative Levels of Serum C-reactive Protein Are Associated With Shorter Long-term Survival After Resection of Colorectal Liver Metastases, Regardless of the Occurrence of Infectious Complications.
    Anticancer Res. 2021;41:2605-2610.
    PubMed     Abstract available


  25. NISHIKAWA H, Fukunishi S, Asai A, Nishiguchi S, et al
    Obesity and Liver Cancer in Japan: A Comprehensive Review.
    Anticancer Res. 2021;41:2227-2237.
    PubMed     Abstract available


    April 2021
  26. MAESAKA K, Sakamori R, Yamada R, Tahata Y, et al
    Efficacy of Ramucirumab Versus Sorafenib as Subsequent Treatment for Hepatocellular Carcinoma.
    Anticancer Res. 2021;41:2187-2192.
    PubMed     Abstract available


  27. FURUKAWA K, Haruki K, Yasuda J, Onda S, et al
    Strategies to Perform Curative Laparoscopic Repeat Hepatectomy for Recurrent Liver Tumors After Open Right Lobectomy.
    Anticancer Res. 2021;41:2171-2175.
    PubMed     Abstract available


  28. SASAKI R, Fukushima M, Haraguchi M, Miuma S, et al
    Liver Function in Older Patients With Unresectable Hepatocellular Carcinoma After Administration of Lenvatinib.
    Anticancer Res. 2021;41:2025-2032.
    PubMed     Abstract available


  29. SHAO C, Shao PP, Chen WT, Lin CC, et al
    Direct-acting Antiviral Therapy Improves the Outcome of Chronic Hepatitis C/intermediate-stage B Hepatocellular Carcinoma Patients.
    Anticancer Res. 2021;41:2007-2016.
    PubMed     Abstract available


  30. YASUHARA Y, Komatsu S, Kuramitsu K, Kido M, et al
    Feasibility of Reductive Hepatectomy in Patients With BCLC B and C Hepatocellular Carcinoma.
    Anticancer Res. 2021;41:1975-1983.
    PubMed     Abstract available


  31. LEE GW, Hur W, Kim JH, Park DJ, et al
    Nardostachys jatamansi Root Extract Attenuates Tumor Progression in Hepatocellular Carcinoma via Inhibition of ERK/STAT3 Pathways.
    Anticancer Res. 2021;41:1883-1893.
    PubMed     Abstract available


  32. NISHINO H, Okuno M, Seo S, Toda R, et al
    Sinusoidal Obstruction Syndrome Promotes Liver Metastatic Seeding of Colorectal Cancer Cells in a Rat Model.
    Anticancer Res. 2021;41:1803-1810.
    PubMed     Abstract available


  33. SHIBA S, Shibuya K, Okamoto M, Okano N, et al
    Carbon-ion Radiotherapy for Oligometastatic Colorectal Cancer in the Liver or Lung.
    Anticancer Res. 2021;41:1997-2005.
    PubMed     Abstract available


    March 2021
  34. PERL RM, Portugall J, Hinterleitner C, Hinterleitner M, et al
    Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
    Anticancer Res. 2021;41:1451-1458.
    PubMed     Abstract available


  35. PARK SY, Seo YR, Ko MJ, Lee JH, et al
    Targeting CALM2 Inhibits Hepatocellular Carcinoma Growth and Metastasis by Suppressing E2F5-mediated Cell Cycle Progression.
    Anticancer Res. 2021;41:1315-1325.
    PubMed     Abstract available


  36. AKIBA J, Yoshida T, Sadashima E, Murata K, et al
    The Expression of PEDF and its Putative Receptors in Hepatocellular Carcinoma and Background Liver Tissue.
    Anticancer Res. 2021;41:1203-1212.
    PubMed     Abstract available


  37. NAKANISHI Y, Hirota S, Hojo Y, Nakamura T, et al
    Pathological Complete Remission of Liver Metastases Correlates With Elimination of Tumor-infiltrating Tregs in Gastric Cancer.
    Anticancer Res. 2021;41:1571-1577.
    PubMed     Abstract available


  38. HIROSE Y, Sakata J, Kobayashi T, Miura K, et al
    NQO1 as a Marker of Chemosensitivity and Prognosis for Colorectal Liver Metastasis.
    Anticancer Res. 2021;41:1563-1570.
    PubMed     Abstract available


    February 2021
  39. LEE HP, Tsai KW, Lee CC
    Prognostic Influence of Cytoplasmic/Nuclear Hepatoma-derived Growth Factor in Head and Neck Cancer.
    Anticancer Res. 2021;41:803-810.
    PubMed     Abstract available


  40. OSAWA M, Matsuda Y, Kinoshita Y, Wakai T, et al
    Urokinase-type Plasminogen Activator Is a Therapeutic Target for Overcoming Sorafenib Resistance in Hepatoma Cells.
    Anticancer Res. 2021;41:645-660.
    PubMed     Abstract available


  41. KABADI SM, Byfield SD, LE L, Olufade T, et al
    Adverse Events and Economic Burden Among Patients Receiving Systemic Treatment for Mantle Cell Lymphoma: A Real-World Retrospective Cohort Study.
    Anticancer Res. 2021;41:927-936.
    PubMed     Abstract available


    January 2021
  42. SAITO R, Amemiya H, Hosomura N, Kawaida H, et al
    Stroke Volume Variation Monitoring to Minimize Blood Loss in Hepatocellular Carcinoma Resection.
    Anticancer Res. 2021;41:409-415.
    PubMed     Abstract available


  43. AMEMIYA H, Matsuda M, Saito R, Hosomura N, et al
    Impact of Insulin Treatment on Prognosis of non-B non-C Hepatocellular Carcinoma After Hepatectomy.
    Anticancer Res. 2021;41:317-326.
    PubMed     Abstract available


  44. FABRITIUS MP, Hartmann F, Seidensticker R, Pech M, et al
    Liver Function Changes After Technetium-99m-Macroaggregated Albumin Administration and Their Predictive Value Regarding Hepatotoxicity in Patients Undergoing Yttrium-90-Radioembolization.
    Anticancer Res. 2021;41:437-444.
    PubMed     Abstract available


  45. KIM EJ, Kim M, Seo S, Kim MJ, et al
    Comparison of Sinusoidal Obstruction Syndrome in Gastric Cancer Patients Receiving S-1/oxaliplatin Versus Capecitabine/oxaliplatin.
    Anticancer Res. 2021;41:391-402.
    PubMed     Abstract available


    December 2020
  46. CHEN SY, Chao CN, Huang HY, Fang CY, et al
    Flavopereirine Inhibits Hepatocellular Carcinoma Cell Growth by Inducing Cell-cycle Arrest, Apoptosis, and Autophagy-related Protein Expression.
    Anticancer Res. 2020;40:6907-6914.
    PubMed     Abstract available


  47. LLUCH P, Segarra G, Tosca J, Navarro L, et al
    Oxidative and Nitrosative Pattern in Circulating Leukocytes of Very Early/Early Hepatocellular Carcinoma Patients.
    Anticancer Res. 2020;40:6853-6861.
    PubMed     Abstract available


  48. ABREU P, Ferreira R, Mineli V, Ribeiro MA, et al
    Alternative Biomarkers to Predict Tumor Biology in Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:6573-6784.
    PubMed     Abstract available


  49. SATO N, Yamamura K, Oda E, Akahoshi S, et al
    Cholangiolocarcinoma With Multiple Recurrences Successfully Treated With Repeated Liver Resection and Radiofrequency Ablation.
    Anticancer Res. 2020;40:7147-7153.
    PubMed     Abstract available


  50. YAMAMOTO J, Sugisawa N, Hamada K, Nishino H, et al
    A Universal Gelfoam 3-D Histoculture Method to Establish Patient-derived Cancer Cells (3D-PDCC) Without Fibroblasts from Patient-derived Xenografts.
    Anticancer Res. 2020;40:6765-6768.
    PubMed     Abstract available


  51. NAKAGAWA N, Tanaka K, Sonohara F, Kandimalla R, et al
    Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.
    Anticancer Res. 2020;40:6665-6676.
    PubMed     Abstract available


  52. PALEK R, Rosendorf J, Maleckova A, Vistejnova L, et al
    Influence of Mesenchymal Stem Cell Administration on The Outcome of Partial Liver Resection in a Porcine Model of Sinusoidal Obstruction Syndrome.
    Anticancer Res. 2020;40:6817-6833.
    PubMed     Abstract available


    November 2020
  53. YAMAMURA K, Beppu T, Kinoshita K, Oda E, et al
    Hepatocellular Carcinoma With Extensive Cancer-associated Thrombosis Successfully Treated With Liver Resection and Direct Oral Anticoagulant: A Case Report.
    Anticancer Res. 2020;40:6465-6471.
    PubMed     Abstract available


  54. DAHLQUIST KJV, Voth LC, Fee AJ, Stoeckman AK, et al
    An Autocrine Role for CXCL1 in Progression of Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:6075-6081.
    PubMed     Abstract available


  55. TOMIOKA K, Aoki T, Matsuda K, Fujimori A, et al
    Usefulness of a Transumbilical Incision for Organ Removal in Laparoscopic Hepatectomy.
    Anticancer Res. 2020;40:6545-6550.
    PubMed     Abstract available


  56. AHMED A, Halama N
    Tertiary Lymphoid Structures in Colorectal Cancer Liver Metastases: Association With Immunological and Clinical Parameters and Chemotherapy Response.
    Anticancer Res. 2020;40:6367-6373.
    PubMed     Abstract available


    October 2020
  57. YAMAMURA K, Beppu T, Sato N, Kinoshita K, et al
    Complete Removal of Adrenal Metastasis in Hepatocellular Carcinoma Using Indocyanine Green Fluorescent Imaging.
    Anticancer Res. 2020;40:5823-5828.
    PubMed     Abstract available


  58. SUGISAWA N, Nishino H, Higuchi T, Park JH, et al
    A Gemcitabine Plus 5-Fluorouracil Combination Inhibits Gastric-Cancer Liver Metastasis in a PDOX Model: A Novel Treatment Strategy.
    Anticancer Res. 2020;40:5393-5397.
    PubMed     Abstract available


    September 2020
  59. NARITA R, Kotoh K, Yoneda A, Motomura M, et al
    Factors Raising Serum Ammonia Level During Lenvatinib Treatment of Patients With Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:5271-5276.
    PubMed     Abstract available


  60. GABATA R, Harada K, Mizutani Y, Ouchi H, et al
    Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against beta-Catenin-activated Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:5211-5219.
    PubMed     Abstract available


  61. NAKURA M, Miyashita T, Yamamoto Y, Takada S, et al
    Inhibitory Effects of Beraprost Sodium in Murine Hepatic Sinusoidal Obstruction Syndrome.
    Anticancer Res. 2020;40:5171-5180.
    PubMed     Abstract available


  62. WU TK, Chen CH, Lee WT, Su TF, et al
    Cetyltrimethylammonium Bromide Suppresses the Migration and Invasion of Hepatic Mahlavu Cells by Modulating Fibroblast Growth Factor Signaling.
    Anticancer Res. 2020;40:5059-5069.
    PubMed     Abstract available


  63. OWADA S, Endo H, Okada C, Yoshida K, et al
    Setanaxib as a Potent Hypoxia-specific Therapeutic Agent Against Liver Cancer.
    Anticancer Res. 2020;40:5071-5079.
    PubMed     Abstract available


    August 2020
  64. GOTO Y, Hisaka T, Sakai H, Takagi K, et al
    Salvage Surgery for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Downstaged by Hepatic Arterial Infusion Chemotherapy.
    Anticancer Res. 2020;40:4773-4777.
    PubMed     Abstract available


  65. KOJIMA S, Hisaka T, Midorikawa R, Naito Y, et al
    Prognostic Impact of Desmoplastic Reaction Evaluation for Intrahepatic Cholangiocarcinoma.
    Anticancer Res. 2020;40:4749-4754.
    PubMed     Abstract available


  66. HAN YH, Li WL, Jin MH, Jin YH, et al
    Peroxiredoxin II Inhibits Alcohol-induced Apoptosis in L02 Hepatocytes Through AKT/beta-Catenin Signaling Pathway.
    Anticancer Res. 2020;40:4491-4504.
    PubMed     Abstract available


  67. KWON JH, Yoo SH, Nam SW, Lee YJ, et al
    Diagnostic Role of Contrast-enhanced Ultrasound in the Discrimination of Malignant Portal Vein Thrombosis in Patients With Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:4351-4363.
    PubMed     Abstract available


  68. HARIMOTO N, Araki K, Ishii N, Muranushi R, et al
    Predictors of Postoperative Ascites After Hepatic Resection in Patients With Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:4343-4349.
    PubMed     Abstract available


  69. HEINZE C, Omari J, Damm R, Hass P, et al
    Interstitial Brachytherapy for Limited (<4 cm) and Large (>/=4 cm) Hepatic Metastases from Rare and Less Common Cancers.
    Anticancer Res. 2020;40:4281-4289.
    PubMed     Abstract available


  70. YUE CH, Chen CH, Lee WT, Su TF, et al
    Cetyltrimethylammonium Bromide Disrupts the Mesenchymal Characteristics of HA22T/VGH Cells Via Inactivation of c-Met/PI3K/Akt/mTOR Pathway.
    Anticancer Res. 2020;40:4513-4522.
    PubMed     Abstract available


  71. HISAKA T, Sakai H, Sato T, Goto Y, et al
    Quercetin Suppresses Proliferation of Liver Cancer Cell Lines In Vitro.
    Anticancer Res. 2020;40:4695-4700.
    PubMed     Abstract available


    July 2020
  72. KIM HC, Joo I, Lee M, Kim YJ, et al
    Radioembolization-induced Tumor Calcifications as a Surrogate Marker of Tumor Response in Patients With Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:4191-4198.
    PubMed     Abstract available


  73. AMANUMA M, Nagai H, Igarashi Y
    Sorafenib Might Induce Sarcopenia in Patients With Hepatocellular Carcinoma by Inhibiting Carnitine Absorption.
    Anticancer Res. 2020;40:4173-4182.
    PubMed     Abstract available


  74. NAKAMURA M, Ueno M, Hayami S, Kawai M, et al
    Effective Response of Intrahepatic Cholangiocarcinoma to Pembrolizumab: A Case Report.
    Anticancer Res. 2020;40:4123-4129.
    PubMed     Abstract available


  75. SHIOGA T, Kondo R, Ogasawara S, Akiba J, et al
    Usefulness of Tumor Tissue Biopsy for Predicting the Biological Behavior of Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:4105-4113.
    PubMed     Abstract available


  76. SAKURAOKA Y, Kubota K, Tanaka G, Shimizu T, et al
    Features of Hepatocellular Carcinoma With Micro Hepatic Vein Invasion and their Correlation With Hepatitis B and C Virus.
    Anticancer Res. 2020;40:3983-3990.
    PubMed     Abstract available


  77. MORIGUCHI M, Aramaki T, Sato R, Iwai K, et al
    Intrahepatic Tumor Burden as a Novel Factor Influencing the Introduction of Second-line Chemotherapy for Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:3953-3960.
    PubMed     Abstract available


  78. IGUCHI T, Sugimachi K, Mano Y, Motomura T, et al
    Prognostic Impact of Geriatric Nutritional Risk Index in Patients With Synchronous Colorectal Liver Metastasis.
    Anticancer Res. 2020;40:4165-4171.
    PubMed     Abstract available


  79. TASHIRO Y, Aoki T, Hirai T, Koizumi T, et al
    Pathological Validity of Using Near-infrared Fluorescence Imaging for Securing Surgical Margins During Liver Resection.
    Anticancer Res. 2020;40:3873-3882.
    PubMed     Abstract available


  80. XIE DP, Gong YX, Jin YH, Ren CX, et al
    Anti-tumor Properties of Picrasma quassioides Extracts in H-Ras(G12V) Liver Cancer Are Mediated Through ROS-dependent Mitochondrial Dysfunction.
    Anticancer Res. 2020;40:3819-3830.
    PubMed     Abstract available


    June 2020
  81. MIYATA T, Takamura H, Kin R, Nishiki H, et al
    Spleen Volume as a Predictive Biomarker for Thrombocytopenia and Liver Dysfunction After Oxaliplatin-based Chemotherapy.
    Anticancer Res. 2020;40:3361-3370.
    PubMed     Abstract available


  82. BAE KB, Kim SH, Kang MS, Kim DH, et al
    An Animal Model of Colorectal Cancer Liver Metastasis With a High Metastasis Rate and Clonal Dynamics.
    Anticancer Res. 2020;40:3297-3306.
    PubMed     Abstract available


    May 2020
  83. KAIDA T, Beppu T, Hayashi H, Imai K, et al
    Inflammatory Liver Tumor Caused by Fasciola hepatica Mimicking Intrahepatic Cholangiocarcinoma.
    Anticancer Res. 2020;40:2795-2800.
    PubMed     Abstract available


  84. LIM SC, Parajuli KR, Han SI
    Role of Death Receptors-associated Lipid Rafts in Oxaliplatin-induced Death Mode Regulation of HepG2 Cells.
    Anticancer Res. 2020;40:2573-2582.
    PubMed     Abstract available


    April 2020
  85. KUZUYA T, Ishigami M, Ito T, Ishizu Y, et al
    Sorafenib vs. Lenvatinib as First-line Therapy for Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis.
    Anticancer Res. 2020;40:2283-2290.
    PubMed     Abstract available


  86. LIU LI, Ahn E, Studeman K, Campbell K, et al
    Primary Hepatic Carcinosarcoma Composed of Hepatocellular Carcinoma, Cholangiocarcinoma, Osteosarcoma and Rhabdomyosarcoma With Poor Prognosis.
    Anticancer Res. 2020;40:2225-2229.
    PubMed     Abstract available


  87. KUZUYA T, Ishigami M, Ito T, Ishizu Y, et al
    Initial Experience of Ramucirumab Treatment After Lenvatinib Failure for Patients With Advanced Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:2089-2093.
    PubMed     Abstract available


  88. JELSKI W, Piechota J, Orywal K, Mroczko B, et al
    The Alterations in Alcohol Dehydrogenase Activity in the Sera of Women With Intrahepatic Cholestasis of Pregnancy.
    Anticancer Res. 2020;40:1997-2001.
    PubMed     Abstract available


  89. LEE J, Seo G, Hur W, Yoon SK, et al
    SRSF3 Depletion Leads to an Increase in SF3B4 Expression in SNU-368 HCC Cells.
    Anticancer Res. 2020;40:2033-2042.
    PubMed     Abstract available


    March 2020
  90. ZARLING L, Emamekhoo H, Bhutani G, Ziemlewicz T, et al
    Polycystic Liver Disease in a Patient With Metastatic Renal Cell Carcinoma: A Case Report.
    Anticancer Res. 2020;40:1527-1534.
    PubMed     Abstract available


  91. PALKOVICS A, Vereczkei A, Fincsur A, Kiss I, et al
    Short- and Long-term Histological Changes in Liver Parenchyma After Different Resection Methods and Their Potential Role in Treatment of Colorectal Liver Metastasis.
    Anticancer Res. 2020;40:1359-1365.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: